Healthcare & Life Sciences
Neuropath
Chinantcotexas.com
Neuropath is a series c plus startup based in China. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2019
Founded
1
Investors
About Neuropath
Based in China, Neuropath is a startup founded in 2019. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Neurophth is a clinical-stage gene therapy company focused on developing AAV-mediated gene therapies for the treatment of ocular genetic diseases.
Explore Neuropath's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.